Search research articles
Contact Us
Filters
Showing results (311-320 of 347) with videos related to
Page
of 35
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas
R Fety, F Rolland, M Barberi-Heyob, et al.
Journal of 3D Printing in Medicine
|
February 25, 2022
The use of 3D-printed models in patient communication: a scoping review
Gemma Traynor, Andrew Iu Shearn, Elena G Milano, et al.
Chemotherapy
|
December 14, 2012
Phase I trial of gemcitabine combined with capecitabine and erlotinib in advanced pancreatic cancer: a clinical and pharmacological study
E Francois, J Bennouna, E Chamorey, et al.
Bulletin Du Cancer
|
March 1, 1993
[Demonstration and characterization of EGF receptors in cancer of the uterine cervix]
J L Lagrange, M Francoual, J L Formento, et al.
Oncology Reports
|
April 18, 2000
A multivariate analysis for predicting cisplatin-induced delayed emesis
X Pivot, N Marghali, M C Etienne, et al.
British Journal of Cancer
|
July 31, 2003
Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil
N Magné, J-L Fischel, C Tiffon, et al.
Anales Espanoles De Pediatria
|
December 1, 1996
[Acute respiratory failure secondary to Pneumocystis carinii pneumonia in children]
M I Martínez Marín, J L de la Mota Ybancos, J Romero García, et al.
Clinical Pharmacology and Therapeutics
|
September 14, 2007
PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression
A S Zandvliet, W S Siegel-Lakhai, J H Beijnen, et al.
Pharmacotherapy
|
December 17, 1997
Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors
J L Lagrange, B Médecin, M C Etienne, et al.
British Journal of Cancer
|
January 19, 2000
Application of an original RT-PCR-ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients
J M Ferrero, M C Etienne, J L Formento, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 347) with videos related to
Sort By:
Page
of 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas
R Fety, F Rolland, M Barberi-Heyob, et al.
Journal of 3D Printing in Medicine
|
February 25, 2022
The use of 3D-printed models in patient communication: a scoping review
Gemma Traynor, Andrew Iu Shearn, Elena G Milano, et al.
Chemotherapy
|
December 14, 2012
Phase I trial of gemcitabine combined with capecitabine and erlotinib in advanced pancreatic cancer: a clinical and pharmacological study
E Francois, J Bennouna, E Chamorey, et al.
Bulletin Du Cancer
|
March 1, 1993
[Demonstration and characterization of EGF receptors in cancer of the uterine cervix]
J L Lagrange, M Francoual, J L Formento, et al.
Oncology Reports
|
April 18, 2000
A multivariate analysis for predicting cisplatin-induced delayed emesis
X Pivot, N Marghali, M C Etienne, et al.
British Journal of Cancer
|
July 31, 2003
Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil
N Magné, J-L Fischel, C Tiffon, et al.
Anales Espanoles De Pediatria
|
December 1, 1996
[Acute respiratory failure secondary to Pneumocystis carinii pneumonia in children]
M I Martínez Marín, J L de la Mota Ybancos, J Romero García, et al.
Clinical Pharmacology and Therapeutics
|
September 14, 2007
PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression
A S Zandvliet, W S Siegel-Lakhai, J H Beijnen, et al.
Pharmacotherapy
|
December 17, 1997
Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors
J L Lagrange, B Médecin, M C Etienne, et al.
British Journal of Cancer
|
January 19, 2000
Application of an original RT-PCR-ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients
J M Ferrero, M C Etienne, J L Formento, et al.
Page
of 35